FDA Inspection
Cohance Lifesciences LimitedCohance Lifesciences Limited – FDA Inspection, Feb 23, 2024
Record Details
This FDA Inspection record concerns Cohance Lifesciences Limited, with an inspection on February 23, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ef957f57-65ad-47f9-a897-5495df26de49
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1234405
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cohance Lifesciences Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2026 | Not classified | Office of Inspections and Investigations | |
| November 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cohance Lifesciences Limited
- FDA Inspection 1335432 - 2026-08-05
- FDA Inspection 1110488 - 2019-11-01
- FDA Inspection 1041216 - 2018-02-15
- FDA Inspection 973825 - 2016-04-14
- FDA Inspection 854615 - 2013-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.